Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Inv. presentation
Quarterly results
Appointed director
CC transcript
Auditor change
Director departure
|
|
JUNIPER PHARMACEUTICALS INC (JNP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/26/2011 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 04/20/2011 |
8-K
| Acquisition/merger/asset purchase announced|
Docs:
|
"Asset Purchase Agreement dated April 20, 2011, between Actient Pharmaceuticals LLC, and Columbia Laboratories, Inc",
"License Agreement dated April 20, 2011, between Actient Pharmaceuticals LLC, and Columbia Laboratories, Inc",
"U.S. Supply Agreement Assignment dated April 20, 2011, between Mipharm S.p.A., and Columbia Laboratories (Bermuda), Ltd",
"License and Supply Agreement dated March 11, 2011, between The Urology Company Limited and Columbia Laboratories (Bermuda), Ltd",
"Actient Pharmaceuticals LLC Acquires U.S. Rights to STRIANT from Columbia Laboratories" |
|
|
|